m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00502)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
RNF40
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5 | ||
Cell Line | NOMO-1 cell line | Homo sapiens |
Treatment: shALKBH5 NOMO-1 cells
Control: shNS NOMO-1 cells
|
GSE144968 | |
Regulation |
|
logFC: 6.81E-01 p-value: 5.37E-04 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In osteosarcoma, ALKBH5 mediates its protumorigenic function by regulating m6A levels of histone deubiquitinase USP22 and the ubiquitin ligase E3 ubiquitin-protein ligase BRE1B (RNF40). | |||
Target Regulation | Up regulation | |||
Responsed Disease | Osteosarcoma | ICD-11: 2B51 | ||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Cell Process | Proteasome pathway degradation | |||
In-vitro Model | U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 |
SaOS-2 | Osteosarcoma | Homo sapiens | CVCL_0548 | |
OS-17 | Osteosarcoma | Homo sapiens | CVCL_9992 | |
IMR-90 | Normal | Homo sapiens | CVCL_0347 | |
hFOB 1.19 | Normal | Homo sapiens | CVCL_3708 | |
143B | Osteosarcoma | Homo sapiens | CVCL_2270 | |
In-vivo Model | For tumor xenograft studies, 143B cells stably expressing scrambled shRNA or ALKBH5 shRNA (1 × 106) were injected subcutaneously into the flanks of 4-week-old athymic nude mice. | |||
Osteosarcoma [ICD-11: 2B51]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | In osteosarcoma, ALKBH5 mediates its protumorigenic function by regulating m6A levels of histone deubiquitinase USP22 and the ubiquitin ligase E3 ubiquitin-protein ligase BRE1B (RNF40). | |||
Responsed Disease | Osteosarcoma [ICD-11: 2B51] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Pathway Response | Ubiquitin mediated proteolysis | hsa04120 | ||
Cell Process | Proteasome pathway degradation | |||
In-vitro Model | U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 |
SaOS-2 | Osteosarcoma | Homo sapiens | CVCL_0548 | |
OS-17 | Osteosarcoma | Homo sapiens | CVCL_9992 | |
IMR-90 | Normal | Homo sapiens | CVCL_0347 | |
hFOB 1.19 | Normal | Homo sapiens | CVCL_3708 | |
143B | Osteosarcoma | Homo sapiens | CVCL_2270 | |
In-vivo Model | For tumor xenograft studies, 143B cells stably expressing scrambled shRNA or ALKBH5 shRNA (1 × 106) were injected subcutaneously into the flanks of 4-week-old athymic nude mice. | |||